Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular Degeneration

NCT01628354 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Choroidal Neovascularization
Retinal Pigment Epithelial Detachment

Interventions

DRUG: Ranibizumab

Sponsor

University of Melbourne